Literature DB >> 31521788

Molecular epidemiology of human respiratory syncytial virus and human metapneumovirus in hospitalized children with acute respiratory infections in Croatia, 2014-2017.

M Jagusic1, A Slovic2, J Ivancic-Jelecki1, S Ljubin-Sternak3, T Vilibić-Čavlek4, I Tabain5, D Forcic1.   

Abstract

Acute respiratory infection (ARI) is the most common infection in children under 5 years of age and it is frequently caused by two pneumoviruses, human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV). Epidemic seasons of these viruses overlap and disease manifestations are highly similar, including severe lower ARI such as bronchiolitis or pneumonia. Reinfections with pneumoviruses are frequent and limited prevention treatment is available. Genetic diversity of HRSV and HMPV strains circulating in Croatia was monitored during four consecutive years (2014-2017). Co-circulation of multiple lineages was observed for both viruses. Within HRSV group A, ON1 strains gained strong predominance during the 4-year period, while previously dominant genotype NA1 was detected only sporadically. Similarly, newly occurring HMPV genotype A2c gained predominance over genotype A2b during this period, resulting in all infection in 2017 being caused by A2c. Along with phylogenetic analysis based on the commonly used fragments for detection and genotyping of these viruses, full length G and SH genes were also analysed. Evolutionary dynamics showed that inferred substitution rates of HRSV and HMPV are between 2.51 × 10-3 and 3.61 × 10-3 substitutions/site/year. This study established presence of recently described HMPV strains containing large duplications in the G gene in Croatia. Viruses with either of the two duplications belong to a subcluster A2c, which has completely replaced all other group A subclusters in 2017.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epidemiology; Evolution; Glycoprotein; Human metapneumovirus; Human respiratory syncytial virus; Small hydrophobic protein

Mesh:

Year:  2019        PMID: 31521788     DOI: 10.1016/j.meegid.2019.104039

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  6 in total

1.  Dominance of the ON1 Genotype of RSV-A and BA9 Genotype of RSV-B in Respiratory Cases from Jeddah, Saudi Arabia.

Authors:  Hessa A Al-Sharif; Sherif A El-Kafrawy; Jehad M Yousef; Taha A Kumosani; Mohammad A Kamal; Norah A Khathlan; Reham M Kaki; Abeer A Alnajjar; Esam I Azhar
Journal:  Genes (Basel)       Date:  2020-11-09       Impact factor: 4.096

Review 2.  Zoonotic Origins of Human Metapneumovirus: A Journey from Birds to Humans.

Authors:  Sonja T Jesse; Martin Ludlow; Albert D M E Osterhaus
Journal:  Viruses       Date:  2022-03-25       Impact factor: 5.818

3.  Global Extension and Predominance of Human Metapneumovirus A2 Genotype with Partial G Gene Duplication.

Authors:  Juan Carlos Muñoz-Escalante; Gabriel Mata-Moreno; Gerardo Rivera-Alfaro; Daniel E Noyola
Journal:  Viruses       Date:  2022-05-16       Impact factor: 5.818

4.  Human Metapneumovirus: Etiological Agent of Severe Acute Respiratory Infections in Hospitalized and Deceased Patients with a Negative Diagnosis of Influenza.

Authors:  Gisela Barrera-Badillo; Beatriz Olivares-Flores; Adriana Ruiz-López; Miguel Ángel Fierro-Valdez; Rosaura Idania Gutiérrez-Vargas; Irma López-Martínez
Journal:  Pathogens       Date:  2020-01-28

5.  Emerging Human Metapneumovirus Gene Duplication Variants in Patients with Severe Acute Respiratory Infection, China, 2017-2019.

Authors:  Zhibo Xie; Jin Xu; Yunhui Ren; Aili Cui; Huiling Wang; Jinhua Song; Qiang Zhang; Manli Hu; Wenbo Xu; Yan Zhang
Journal:  Emerg Infect Dis       Date:  2021-01       Impact factor: 6.883

Review 6.  Host Components That Modulate the Disease Caused by hMPV.

Authors:  Nicolás M S Gálvez; Catalina A Andrade; Gaspar A Pacheco; Jorge A Soto; Vicente Stranger; Thomas Rivera; Abel E Vásquez; Alexis M Kalergis
Journal:  Viruses       Date:  2021-03-22       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.